(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RNASE PARA USO NO TRATAMENTO OU PREVENÇÃO DE INFECÇÕES VIRAIS

ArquivadaInvention PatentPCT · US2015022670

Application data

Number

112016022214

Type

Invention Patent

Filing

03/26/2015

Publication

10/24/2017

PCT

US2015022670

Progress at the INPI

  1. Filing03/26/15
  2. Publication10/24/17
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 03/26/2015 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 06/26/2018. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TAMIR BIOTECHNOLOGY, INC.

US

Inventors

T. H. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

14/229,816 · 03/28/2014

US

14/247,723 · 04/08/2014

US

14/316,893 · 06/27/2014

US

14/667,282 · 03/24/2015

US

62/040,885 · 08/22/2014

US

62/063,551 · 10/14/2014

US

62/102,671 · 01/13/2015

Abstract

A presente invenção refere-se às ribonucleases da super-família da RNase A ou um derivado funcional da mesma que são de um modo geral úteis para o tratamento ou a prevenção de infecções virais causadas pelas viroses classificadas nos Grupos I, II, IV e V de Baltimore nos indivíduos mamíferos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

06/26/2018

RPI 2477

Arquivamento - Art. 33 da LPI

#11.1

04/10/2018

RPI 2466

Notificação de entrada na fase nacional - PCT

#1.3

10/24/2017

RPI 2442

Alteração de dados cadastrais

#1.1

11/01/2016

RPI 2391

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.